Jorg Baumgarten

Person

Wuppertal, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Cytostatic conjugates with integrin ligands
- Patent number 7,304,037
- Issue date Dec 4, 2007
- Bayer Akiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Integrin-mediated drug targeting
- Patent number 7,220,824
- Issue date May 22, 2007
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopentabenzofuran derivatives and their use
- Patent number 6,943,182
- Issue date Sep 13, 2005
- Bayer Aktiengesellschaft
- Walter Guarnieri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted α, β-anellated butyrolactones
- Patent number 6,723,718
- Issue date Apr 20, 2004
- Bayer Aktiengesellschaft
- Andreas Stolle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trioxane derivatives
- Patent number 6,649,647
- Issue date Nov 18, 2003
- Richard Haynes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of cyclopentabenzofuran-derivatives for combating (NF-κB...
- Patent number 6,518,274
- Issue date Feb 11, 2003
- Bayer Aktiengesellschaft
- Matthias Gehling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of galiella lactone
- Patent number 6,512,007
- Issue date Jan 28, 2003
- Bayer Aktiengesellschaft
- Jörg Baumgarten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
20(S) camptothecin glycoconjugates
- Patent number 6,506,734
- Issue date Jan 14, 2003
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted α, β-anellated butyrolactones
- Patent number 6,462,074
- Issue date Oct 8, 2002
- Bayer Aktiengesellschaft
- Andreas Stolle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted β,γ-anellated lactones
- Patent number 6,433,004
- Issue date Aug 13, 2002
- Bayer Aktiengesellschaft
- Andreas Stolle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopentabenzofuran derivatives and their use
- Patent number 6,420,393
- Issue date Jul 16, 2002
- Bayer Aktiengesellschaft
- Walter Guarnieri
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted bicyclic lactones
- Patent number 6,376,539
- Issue date Apr 23, 2002
- Bayer Aktiengesellschaft
- Andreas Stolle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sugar-modified cytostatics
- Patent number 6,271,342
- Issue date Aug 7, 2001
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycoconjugates of modified camptothecin derivatives (A-or B-ring l...
- Patent number 6,156,754
- Issue date Dec 5, 2000
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pseudorabies virus (PRV) polynucleotides and their use for preparin...
- Patent number 5,798,265
- Issue date Aug 25, 1998
- Bayer Aktiengesellschaft
- Wolfgang Springer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HIV antisense expression vectors
- Patent number 5,583,035
- Issue date Dec 10, 1996
- Bayer Aktiengesellschaft
- Axel Kretschmer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Apparatus for the cultivation of immobilized micro-organisms
- Patent number 5,166,072
- Issue date Nov 24, 1992
- Bayer Aktiengesellschaft
- Jorg Krauling
- C02 - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
Information Patent Grant
Preparation of immunologically active cell wall components from arc...
- Patent number 5,091,364
- Issue date Feb 25, 1992
- Bayer Aktiengesellschaft
- Jorg Baumgarten
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biologically active composition for purifying waste water and outgo...
- Patent number 4,681,851
- Issue date Jul 21, 1987
- Bayer Aktiengesellschaft
- Jorg Baumgarten
- C02 - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
Information Patent Grant
Immobilization of cells in polyurethane hydrogel
- Patent number 4,634,672
- Issue date Jan 6, 1987
- Bayer Aktiengesellschaft
- Jorg Baumgarten
- C02 - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
Information Patent Grant
Preparations of micro-organisms
- Patent number 4,391,887
- Issue date Jul 5, 1983
- Bayer Aktiengesellschaft
- Jorg Baumgarten
- B09 - DISPOSAL OF SOLID WASTE RECLAMATION OF CONTAMINED SOIL SOIL

Patents Applicationslast 30 patents

Information Patent Application
Novel cytostatic conjugates with integrin ligands
- Publication number 20080108576
- Publication date May 8, 2008
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Integrin-Mediated drug targeting
- Publication number 20060189544
- Publication date Aug 24, 2006
- Bayer Aktiengesellschaft
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted alpha, beta-anellated butyrolactones
- Publication number 20030158424
- Publication date Aug 21, 2003
- Andreas Stolle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclopentabenzofuran derivatives and their use
- Publication number 20030144334
- Publication date Jul 31, 2003
- Walter Guarnieri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel cytostatic conjugates with integrin ligands
- Publication number 20020193311
- Publication date Dec 19, 2002
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cytostatic-integrin conjugates having specifically cleavable linkin...
- Publication number 20020183256
- Publication date Dec 5, 2002
- Hans-Georg Lerchen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED CYTOSTATIC AGENTS
- Publication number 20020173468
- Publication date Nov 21, 2002
- HANS-GEORG LERCHEN
- C07 - ORGANIC CHEMISTRY

Jorg Baumgarten

Person

Patents Grantslast 30 patents

Cytostatic conjugates with integrin ligands

Integrin-mediated drug targeting

Cyclopentabenzofuran derivatives and their use

Substituted &#x03B1;, &#x03B2;-anellated butyrolactones

Trioxane derivatives

Use of cyclopentabenzofuran-derivatives for combating (NF-&#x03BA;B...

Use of galiella lactone

20(S) camptothecin glycoconjugates

Substituted &#x03B1;, &#x03B2;-anellated butyrolactones

Substituted &#x03B2;,&#x03B3;-anellated lactones

Cyclopentabenzofuran derivatives and their use

Substituted bicyclic lactones

Sugar-modified cytostatics

Glycoconjugates of modified camptothecin derivatives (A-or B-ring l...

Pseudorabies virus (PRV) polynucleotides and their use for preparin...

HIV antisense expression vectors

Apparatus for the cultivation of immobilized micro-organisms

Preparation of immunologically active cell wall components from arc...

Biologically active composition for purifying waste water and outgo...

Immobilization of cells in polyurethane hydrogel

Preparations of micro-organisms

Patents Applicationslast 30 patents

Novel cytostatic conjugates with integrin ligands

Integrin-Mediated drug targeting

Substituted alpha, beta-anellated butyrolactones

Cyclopentabenzofuran derivatives and their use

Novel cytostatic conjugates with integrin ligands

Cytostatic-integrin conjugates having specifically cleavable linkin...

MODIFIED CYTOSTATIC AGENTS

Substituted α, β-anellated butyrolactones

Use of cyclopentabenzofuran-derivatives for combating (NF-κB...

Substituted α, β-anellated butyrolactones

Substituted β,γ-anellated lactones